For the quarter ending 2025-09-30, PMN made $11,920,738 in revenue. -$11,580,126 in net income. Net profit margin of -97.14%.
| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Research and development | 9,797,418 | |||
| General and administrative | 1,953,014 | |||
| Total operating expenses | 11,750,432 | |||
| Loss from operations | -11,750,432 | |||
| Other income | 170,306 | |||
| Total other income, net | 170,306 | |||
| Net (loss) income | -11,580,126 | |||
| Earnings per share, basic | -0.24 | |||
| Earnings per share, diluted | -0.24 | |||
| Weighted average number of shares outstanding, basic | 48,833,799 | |||
| Weighted average number of shares outstanding, diluted | 48,833,799 | |||
ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Inc. (PMN)